-
41.发明授权公开(公告)号：US07259262B2
公开(公告)日：2007-08-21
申请号：US10965996
申请日：2004-10-15
IPC分类号： C07D263/32 , C07D277/22 , A01N43/76 , A01N43/78
CPC分类号： C07D417/14 , C07D413/14
摘要： There are presented compounds of formula (I) their pharmaceutically acceptable salts, enantiomeric forms thereof, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 提供式（I）化合物的药学上可接受的盐，其对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物在 控制或预防癌症等疾病。
-
公开(公告)号：US20060246041A1
公开(公告)日：2006-11-02
申请号：US11396946
申请日：2006-04-03
申请人： Karin Lauer , Kurt Lang , Apollon Papadimitriou , Ulrike Reiff , Michaela Schulz , Torsten Blunk , Achim Goepferich
发明人： Karin Lauer , Kurt Lang , Apollon Papadimitriou , Ulrike Reiff , Michaela Schulz , Torsten Blunk , Achim Goepferich
CPC分类号： A61L27/3852 , A61L27/3612 , A61L27/3654 , A61L27/3843 , A61L2430/06
摘要： The present invention makes available an optimal concentration of a hedgehog polypeptide for modulating growth and/or cartilage production by chondrocytes. The present invention allows for improvements in the culturing of chondrocytes to develop cartilaginous tissue ex vivo suitable for implantation to replace damaged or deteriorated cartilage in a patient.
-
公开(公告)号：US20050038091A1
公开(公告)日：2005-02-17
申请号：US10910765
申请日：2004-08-03
IPC分类号： C07D413/12 , C07D413/02 , A61K31/422
CPC分类号： C07D413/12
摘要： The present invention relates to novel oxazoles of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明涉及式（I）的新颖恶唑，其药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述用途 控制或预防疾病如癌症的化合物。
-
44.发明申请Tricyclic Lactam Derivatives, Their Manufacture and Use as Pharmaceutical Agents 审中-公开三环内酰胺衍生物，其制造和用作药剂公开(公告)号：US20090143375A1
公开(公告)日：2009-06-04
申请号：US12084531
申请日：2006-12-13
申请人： Guy Georges , Bernhard Goller , Hans-Willi Krell , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth , Christine Schuell , Mark Stahl
发明人： Guy Georges , Bernhard Goller , Hans-Willi Krell , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth , Christine Schuell , Mark Stahl
IPC分类号： A61K31/4188 , C07D487/04 , A61P29/00 , A61P9/00 , A61P35/00 , A61P25/00 , A61K31/5377
CPC分类号： C07D487/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物 控制或预防癌症等疾病。
-
公开(公告)号：US07432291B2
公开(公告)日：2008-10-07
申请号：US11083176
申请日：2005-03-17
IPC分类号： A61K31/41 , C07D249/04
CPC分类号： C07D417/12 , C07D413/12 , C07D413/14
摘要： The present invention provides the compounds of formula (I) their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, compositions containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明提供式（I）化合物的药学上可接受的盐或酯，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的组合物及其制备方法，以及上述用途， 提及的化合物在控制或预防诸如癌症的疾病中。
-
公开(公告)号：US07247649B2
公开(公告)日：2007-07-24
申请号：US10910765
申请日：2004-08-03
IPC分类号： A61K31/422 , C07D263/30 , C07D413/12
CPC分类号： C07D413/12
摘要： The present invention relates to novel oxazoles of formula (I) their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明涉及式（I）的新颖恶唑，其药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述用途 控制或预防疾病如癌症的化合物。
-
公开(公告)号：US20060235065A1
公开(公告)日：2006-10-19
申请号：US11384052
申请日：2006-03-17
申请人： Guy Georges , Bernhard Goller , Klaus-Peter Kuenkele , Aude Lemarchand , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth
发明人： Guy Georges , Bernhard Goller , Klaus-Peter Kuenkele , Aude Lemarchand , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth
IPC分类号： A61K31/4188 , C07D487/02
CPC分类号： C07D487/04
摘要： The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明涉及式I化合物：其药学上可接受的盐或酯，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物组合物及其制备，以及这些化合物的用途 控制或预防癌症等疾病。
-
公开(公告)号：US20060069095A1
公开(公告)日：2006-03-30
申请号：US11232303
申请日：2005-09-21
IPC分类号： A61K31/5377 , A61K31/422 , C07D413/02 , C07D413/14
CPC分类号： C07D413/12
摘要： Compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, are disclosed. Also disclosed are methods of preparation of the above-mentioned compounds, pharmaceutical compositions and salts and esters thereof containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.
摘要翻译： 式I化合物
-
-
-
-
-
-
-
搜索结果
48 条记录 (耗时 0.043 秒)
